Post-approval studies (Phase 4)WithdrawnNCT02760615What this trial is testingPhase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction StudyWho this might be right forColitis, UlcerativeCrohn Disease Takeda
Testing effectiveness (Phase 2)Ended earlyNCT04130919What this trial is testingStudy to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis Gilead Sciences 19
Not applicableStudy completedNCT04294615What this trial is testingClinical Response and Safety Following FMT for UCWho this might be right forInflammatory Bowel DiseasesFecal Microbiota Transplantation Air Force Military Medical University, China 9
Testing effectiveness (Phase 2)Looking for participantsNCT07229950What this trial is testingClinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel DiseaseWho this might be right forAdult Patients With Moderately to Severely Active Ulcerative Colitis Shandong Suncadia Medicine Co., Ltd. 48
Large-scale testing (Phase 3)Study completedNCT00679432What this trial is testing(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative ColitisWho this might be right forUlcerative Colitis Bausch Health Americas, Inc. 510
Early research (Phase 1)Study completedNCT04254783What this trial is testingEvaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's DiseaseWho this might be right forUlcerative Colitis (UC)Crohn's Disease AbbVie 20
Large-scale testing (Phase 3)Looking for participantsNCT07184996What this trial is testingAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis Sanofi 980
Large-scale testing (Phase 3)WithdrawnNCT04469062What this trial is testingMirikizumab (LY3074828) in Participants With Ulcerative ColitisWho this might be right forUlcerative Colitis Eli Lilly and Company
Very early researchUnknownNCT02390726What this trial is testingFecal Microbiota Transplant in the Treatment of Ulcerative ColitisWho this might be right forUlcerative Colitis, Active Moderate University of Vermont 20
Testing effectiveness (Phase 2)UnknownNCT02768974What this trial is testingOpen Label Study to Assess Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative ColitisWho this might be right forUlcerative Colitis Protalix 20
Large-scale testing (Phase 3)Active Not RecruitingNCT03519945What this trial is testingEvaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)Who this might be right forUlcerative Colitis Eli Lilly and Company 1,058
Large-scale testing (Phase 3)Ended earlyNCT05644665What this trial is testingEvaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis Bristol-Myers Squibb 131
Testing effectiveness (Phase 2)Active Not RecruitingNCT06029972What this trial is testingStudy of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis Gilead Sciences 176
Testing effectiveness (Phase 2)Ended earlyNCT00152841What this trial is testingEffect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative ColitisWho this might be right forCrohn's DiseaseUlcerative ColitisMild or Moderate Anaemia University Health Network, Toronto 30
Not applicableActive Not RecruitingNCT01848561What this trial is testingA Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis (UC) AbbVie 8,250
Large-scale testing (Phase 3)UnknownNCT04176588What this trial is testingEtrasimod in Subjects With Moderately to Severely Active Ulcerative ColitisWho this might be right forModerately to Severely Active Ulcerative Colitis Everstar Therapeutics Limited 341
Large-scale testing (Phase 3)Study completedNCT00853099What this trial is testingAdalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis AbbVie (prior sponsor, Abbott) 274
Testing effectiveness (Phase 2)Looking for participantsNCT06979336What this trial is testingEvaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis Genentech, Inc. 224
Testing effectiveness (Phase 2)Looking for participantsNCT07080034What this trial is testingStudy of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative ColitisWho this might be right forUlcerative Colitis (UC) Biocad 198
Testing effectiveness (Phase 2)Ended earlyNCT03616821What this trial is testingPlacebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative ColitisIBD AstraZeneca 242